Evidence map›Paper›PMID 38971504›Full record

ArticleNeurochemistry international2024

Stroke triggers dynamic m

Suresh L Mehta, Hadjer Namous, Raghu Vemuganti

Abstract read
In one paragraph

Article in Neurochemistry international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Suresh L MehtaDepartment of Neurological Surgery, University of Wisconsin, Madison, WI, USA.
Hadjer NamousDepartment of Neurological Surgery, University of Wisconsin, Madison, WI, USA.
Raghu VemugantiDepartment of Neurological Surgery, University of Wisconsin, Madison, WI, USA; William S. Middleton Memorial Veteran Administration Hospital, Madison, WI, USA. Electronic address: vemuganti@neurosurgery.wisc.edu.

Funding

Role of RNAs in post-stroke brain damageR35NS132184 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI Raghu VEMUGANTI · 2023 to 2026
$4.1M
Epitranscriptomic regulation by m6A RNA methylation after strokeR01NS130763 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI VEMUGANTI, RAGHU · 2023 to 2023
$618k
miR-21 induced neuroprotection after strokeI01BX005127 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI Raghu VEMUGANTI · 2022 to 2026
–
Ascorbate protects brain after TBI by epigenetic modulation of 5-hydroxymethylationI01BX006062 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI Raghu VEMUGANTI · 2024 to 2026
–
BLRD Research Career Scientist Award ApplicationIK6BX005690 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI VEMUGANTI, RAGHU · 2021 to 2025
–
BLRD VA I01 BX005127BLRD VA I01 BX006062BLRD VA IK6 BX005690NINDS NIH HHS R01 NS130763NINDS NIH HHS R35 NS132184
6 · The paper itself

Abstract

We previously showed that stroke alters circular RNA (circRNA) expression profiles. Many circRNAs undergo epitranscriptomic modifications, particularly methylation of adenosine to form N

Indexed as

AdenosineMice, Inbred C57BLRNA, CircularStrokeAnimalsMaleMethylationMiceRNAAdenosineN-methyladenosineRNARNA, CircularCerebral ischemiaN(6)-methyladenosineNoncoding RNARegulation

Identifiers

PMID38971504
PMCPMC11296895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.